
|Articles|July 1, 1998
Supplements and Featured Publications
- New and Emerging Therapies in the Treatment of Hypertension and Congestive Heart Failure
- Volume 4
- Issue 7 Suppl
European Society of Cardiology: Angiotensin II Antagonists: Why is There So Much Excitement?
Author(s)Norman K. Hollenberg, MD
Advertisement
Articles in this issue
over 27 years ago
Participating Facultyover 27 years ago
Gene Polymorphism Influences Response to Angiotensin Blockadeover 27 years ago
New Drug Class Offers Benefits in Heart Failureover 27 years ago
Exploring the Benefits Beyond Blood Pressure ControlNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Hereditary Ovarian Cancer Genes Found Beyond Traditionally High-Risk Groups
2
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
3
Medicaid Expansion Associated With Lower Mortality in NSCLC
4
ACIP Delayed Hepatitis B Vaccine Schedule Vote Amid Safety Controversy
5














































